A Multicenter, Randomized, Double-blind, Placebo- Controlled Phase 2b Dose-finding Study to Investigate the Efficacy, Safety and Tolerability of LOU064 in Adult Chronic Spontaneous Urticaria (CSU) Patients Inadequately Controlled by H1-antihistamines

Name: A Multicenter, Randomized, Double-blind, Placebo- Controlled Phase 2b Dose-finding Study to Investigate the Efficacy, Safety and Tolerability of LOU064 in Adult Chronic Spontaneous Urticaria (CSU) Patients Inadequately Controlled by H1-antihistamines
Creator: Vivli
Published: 2026-03-27 13:34:57
License: 暂无描述

DataCite Commons2026-03-27 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00012933/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

This was a multicenter, randomized, double-blind and placebo-controlled phase 2b dose-finding study to assess the efficacy and safety of LOU064 in adults chronic spontaneous urticaria (CSU) patients inadequately controlled by H1-antihistamines

提供机构：

Vivli

创建时间：

2026-03-27